CADASIL: management
Evidence-based neurology checklist on cadasil: management: Magnetic resonance imaging (MRI): features High signal changes in the anterior temporal poles Diffuse white matter high signal changes Microbleeds: these are usually in the thalamus Cerebrospinal fluid (CSF) analysis Genetics Other…
Magnetic resonance imaging (MRI): features
- High signal changes in the anterior temporal poles
- Diffuse white matter high signal changes
- Microbleeds: these are usually in the thalamus
Cerebrospinal fluid (CSF) analysis
Genetics
Other investigations
Treatment of vasculopathy
Treatment of migraine
Acronym
References
- Adib-Samii P, Brice G, Martin RJ, Markus HS. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype study in 200 consecutively recruited individuals. Stroke 2010; 41:630-634.
- Oberstein SAJL, van den Boom R, van Buchem MA, et al. Cerebral microbleeds in CADASIL. Neurology 2001; 57:1066.
- Razvi SSM, Muir KW. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Pract Neurol 2004; 4:50-55.
- Pantoni L, Pescini F, Nannucci S, et al. Comparison of clinical, familial, and MRI features of CADASIL and-negative patients NOTCH3. Neurology 2010; 74:57–63.
- Chabriat H, Hervé D, Duering M, et al. Predictors of clinical worsening in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: prospective cohort study. Stroke 2016; 47:4-11.
- And 3 more. Subscribe to see the full list
